Aide Chemists key facts
as of Oct 2026- Developer of a pharmaceutical and digital health platform designed to improve healthcare access and outcomes in Ghana.
- Aide Chemists is valued at approximately $13.0M as of Oct 2026 (last reported valuation).
- It has raised $2.6M; the latest was Seed Round ($2.0M) in Sep 2025.
- Notable investors include Microsoft for Startups, Healthtech Hub, African Union Development Agency-NEPAD, Japan International Cooperation Agency, Norrsken Evolve — 6 tracked in total.
- Status: Privately Held (backing).
Aide Chemists's last reported valuation, Sep 2025. Nothing priced has surfaced since.
- ·Watch Aide Chemists: the Monday email on marks, rounds and moves
Aide Chemists funding rounds
No funding rounds for Aide Chemists are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Aide Chemists valuation
Aide Chemists's last reported valuation was $13 million in Sep 2025. No priced round, secondary trade or fund mark has surfaced since.
Aide Chemists investors
6 investors are on record for Aide Chemists, including Microsoft for Startups, Healthtech Hub, African Union Development Agency-NEPAD and Japan International Cooperation Agency.
About Aide Chemists
Developer of a pharmaceutical and digital health platform designed to improve healthcare access and outcomes in Ghana. The company offers an online pharmacy, a mobile application for medicine ordering, a health assistant for symptom triage and prescription support, and a loyalty program for regular users, enabling individuals to access affordable medicines, receive trusted health guidance, and support pharmacy growth through a franchise-based model.
- Sector
- Healthcare
- HQ
- Accra, Ghana
- Founded
- 2014
- Employees
- 42
- Website
- aidechemist.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.